Creative Planning’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-200
Closed -$7.83K 2790
2023
Q3
$7.83K Buy
+200
New +$7.96K ﹤0.01% 2676
2022
Q2
Sell
-610
Closed -$28K 2307
2022
Q1
$28K Buy
+610
New +$27K ﹤0.01% 2110
2021
Q2
Sell
-4,579
Closed -$212K 2130
2021
Q1
$212K Buy
+4,579
New +$217K ﹤0.01% 2056
2017
Q1
Sell
-3,400
Closed -$108K 4657
2016
Q4
$108K Buy
3,400
+3,200
+1,600% +$107K ﹤0.01% 1814
2016
Q3
$7K Buy
+200
New +$7.07K ﹤0.01% 3706
2015
Q4
Sell
-2,513
Closed -$94K 4411
2015
Q3
$94K Buy
+2,513
New +$111K ﹤0.01% 1631
2015
Q1
Sell
-138
Closed -$6K 4215
2014
Q4
$6K Buy
+138
New +$5.67K ﹤0.01% 3384

Other funds holding BME

Creative Planning's BME Position: Q4 2023 in Review

Creative Planning sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 200 shares — an estimated $7.83K sold.

Creative Planning first reported a position in BME in Q4 2014 and held it in 7 quarters. The position peaked at $212K in Q1 2021. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Creative Planning reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Creative Planning sold 200 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $7.83K.
  • Creative Planning first reported a position in BlackRock Health Sciences Trust in Q4 2014 and held it in 7 quarters.
  • Creative Planning's BlackRock Health Sciences Trust position peaked at $212K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.